|
Taiwan Academic Institutional Repository >
Browse by Author
|
"su y y"
Showing items 1-10 of 41 (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page
國立成功大學 |
2023 |
Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study
|
Lin, M.-Y.;Wu, C.-L.;Su, Y.-Y.;Huang, C.-J.;Chang, W.-L.;Sheu, B.-S. |
國立成功大學 |
2023 |
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
|
Su, Y.-Y.;Chiang, N.-J.;Chang, J.S.;Wang, Y.-W.;Shen, B.-N.;Li, Y.-J.;Hwang, D.-Y.;Shan, Y.-S.;Chen, L.-T. |
臺大學術典藏 |
2022-08-19T00:20:28Z |
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives
|
Su Y.-Y.; Lin Y.-J.; Li C.-C.; CHIUN HSU |
臺大學術典藏 |
2022-03-08T03:44:01Z |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T. |
臺大學術典藏 |
2022-03-08T03:44:01Z |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study
|
Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. |
臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
國立成功大學 |
2022 |
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
|
Chiang, N.-J.;Tan, K.T.;Bai, L.-Y.;Hsiao, C.-F.;Huang, C.-Y.;Hung, Y.-P.;Huang, C.-J.;Chen, S.-C.;Shan, Y.-S.;Chao, Y.;Huang, Y.-H.;Lee, I.-C.;Lee, P.-C.;Su, Y.-Y.;Chen, S.-J.;Yeh, C.-N.;Chen, L.-T.;Chen, M.-H. |
國立成功大學 |
2022 |
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chiu, T.-J.;Yang, S.-H.;Chiu, S.-C.;Hsueh, S.-W.;Chiang, N.-J.;Li, C.-P.;Bai, L.-Y.;Cheng, F.-M.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Su, Y.-Y.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C. |
國立成功大學 |
2022 |
Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway
|
Hung, Y.-H.;Hsu, S.-H.;Hou, Y.-C.;Chu, P.-Y.;Su, Y.-Y.;Shan, Y.-S.;Hung, W.-C.;Chen, L.-T. |
臺大學術典藏 |
2021-09-17T07:13:03Z |
Corrigendum to “Morbidity and mortality of very low birth weight infants in Taiwan—Changes in 15 years: A population based study” [Journal of the Formosan Medical Association 115 (2016) 1039–1045](S0929664616303461)(10.1016/j.jfma.2016.10.011)
|
Su Y.-Y.; Wang S.-H.; Chou H.-C.; CHIEN-YI CHEN; Hsieh W.-S.; Tsao P.-N.; Tsou K.-I.; Hsu C.-H.; Mu S.-C.; Lin H.-C.; Huang C.-C.; Hsieh K.-S.; Taiwan Premature Infant Follow-up Network |
Showing items 1-10 of 41 (5 Page(s) Totally) 1 2 3 4 5 > >> View [10|25|50] records per page
|